BB Biotech Stock Forward View - Relative Strength Index
| BION Stock | CHF 46.70 0.35 0.74% |
BION Stock outlook is based on your current time horizon.
At this time, The RSI of BB Biotech's share price is at 53 suggesting that the stock is in nutural position, most likellhy at or near its resistance level. The main idea of RSI analysis is to track how fast people are buying or selling BB Biotech, making its price go up or down. Momentum 53
Impartial
Oversold | Overbought |
Quarterly Earnings Growth (0.46) | EPS Estimate Current Year 9.82 | EPS Estimate Next Year 4.91 | Wall Street Target Price 47.7 | Quarterly Revenue Growth 11.406 |
Using BB Biotech hype-based prediction, you can estimate the value of BB Biotech AG from the perspective of BB Biotech response to recently generated media hype and the effects of current headlines on its competitors.
BB Biotech after-hype prediction price | CHF 46.7 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BION |
BB Biotech Additional Predictive Modules
Most predictive techniques to examine BION price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BION using various technical indicators. When you analyze BION charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Previous Relative Strength Index | Relative Strength Index | Trend |
| 53.15 | 53.15 |
| Check BB Biotech Volatility | Backtest BB Biotech | Information Ratio |
BB Biotech Trading Date Momentum
| On February 02 2026 BB Biotech AG was traded for 46.70 at the closing time. The highest price during the trading period was 47.15 and the lowest recorded bid was listed for 46.30 . There was no trading activity during the period 0.0. Lack of trading volume on February 2, 2026 did not affect price variability. The overall trading delta to the current price is 0.32% . |
| Compare BB Biotech to competition |
Other Forecasting Options for BB Biotech
For every potential investor in BION, whether a beginner or expert, BB Biotech's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BION Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BION. Basic forecasting techniques help filter out the noise by identifying BB Biotech's price trends.BB Biotech Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BB Biotech stock to make a market-neutral strategy. Peer analysis of BB Biotech could also be used in its relative valuation, which is a method of valuing BB Biotech by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BB Biotech Market Strength Events
Market strength indicators help investors to evaluate how BB Biotech stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BB Biotech shares will generate the highest return on investment. By undertsting and applying BB Biotech stock market strength indicators, traders can identify BB Biotech AG entry and exit signals to maximize returns.
BB Biotech Risk Indicators
The analysis of BB Biotech's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BB Biotech's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bion stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 1.36 | |||
| Semi Deviation | 1.52 | |||
| Standard Deviation | 1.76 | |||
| Variance | 3.09 | |||
| Downside Variance | 3.27 | |||
| Semi Variance | 2.32 | |||
| Expected Short fall | (1.53) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Story Coverage note for BB Biotech
The number of cover stories for BB Biotech depends on current market conditions and BB Biotech's risk-adjusted performance over time. The coverage that generates the most noise at a given time depends on the prevailing investment theme that BB Biotech is classified under. However, while its typical story may have numerous social followers, the rapid visibility can also attract short-sellers, who usually are skeptical about BB Biotech's long-term prospects. So, having above-average coverage will typically attract above-average short interest, leading to significant price volatility.
Other Macroaxis Stories
Our audience includes start-ups and big corporations as well as marketing, public relation firms, and advertising agencies, including technology and finance journalists. Our platform and its news and story outlet are popular among finance students, amateur traders, self-guided investors, entrepreneurs, retirees and baby boomers, academic researchers, financial advisers, as well as professional money managers - a very diverse and influential demographic landscape united by one goal - build optimal investment portfolios
Story Categories
Currently Trending Categories
BB Biotech Short Properties
BB Biotech's future price predictability will typically decrease when BB Biotech's long traders begin to feel the short-sellers pressure to drive the price lower. The predictive aspect of BB Biotech AG often depends not only on the future outlook of the potential BB Biotech's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BB Biotech's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 54.8 M | |
| Cash And Short Term Investments | 2.4 B |
Additional Tools for BION Stock Analysis
When running BB Biotech's price analysis, check to measure BB Biotech's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BB Biotech is operating at the current time. Most of BB Biotech's value examination focuses on studying past and present price action to predict the probability of BB Biotech's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BB Biotech's price. Additionally, you may evaluate how the addition of BB Biotech to your portfolios can decrease your overall portfolio volatility.